Sat.Jan 30, 2021 - Fri.Feb 05, 2021

article thumbnail

Bristol Myers finally wins FDA approval for cancer cell therapy

Bio Pharma Dive

Delays tied to factory inspections had pushed an FDA decision on Breyanzi past a key deadline, allowing Bristol Myers to avoid paying billions of dollars in payouts to investors.

article thumbnail

Pharma’s horrible website metrics

World of DTC Marketing

SUMMARY: The number of visitors to your website doesn’t mean anything if you have high bounce rates and low page views/time on site. More than half of mobile users leave a website that takes more than three seconds to load, yet too many pharma sites are not optimized for mobile. Houston, we have a problem. Attention spans online are declining rapidly.

Branding 187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

White paper reveals pathway for digital therapeutics use in Italy

pharmaphorum

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and

article thumbnail

New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab

Pharma Times

The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy

Bio Pharma Dive

Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine.

article thumbnail

The biggest threat to the pharma industry

World of DTC Marketing

SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. It’s reshaping the company to once again focus on patients instead of profits. At the end of last year, I worked with a leading cancer company on a test program that involved an email program. We started with research to uncover the needs and wants of current cancer patients (NSC lung) and caregivers.

Branding 187

More Trending

article thumbnail

Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production

XTalks

As COVID-19 vaccines continue to be in short supply around the world, pharma giants such as Bayer (Nasdaq: BAYRY ) are stepping up to help fulfill the need. Bayer has agreed to assist in the manufacturing of an mRNA-based coronavirus vaccine, CVnCOV, developed by fellow German biopharma company CureVac (Nasdaq: CVAC ). In early January, Bayer also struck an agreement with the company to support the further development, supply and key territory operations of CureVac’s COVID-19 vaccine candidate.

article thumbnail

Biogen laser-focused on Alzheimer's drug as rest of business falters

Bio Pharma Dive

While the biotech prepares to launch aducanumab, its latest earnings report shows significant hits to top-selling drugs, plus another pipeline failure.

Drugs 343
article thumbnail

Pharma throwing money away on digital ads

World of DTC Marketing

SUMMARY: Digital ad spend in pharmaceutical brands is up 111% so far in 2020 and 80% of that money is being thrown away by fraud and the popularity of programmatic advertising. While popular, digital advertising wasn’t an immediate hit in the pharmaceuticals arena due to the strict regulations. Pharmaceutical advertisers have traditionally been slow to join with the latest trends simply because it’s more complicated for regulated industries.

Branding 187
article thumbnail

Not every cough is COVID – MSD UK’s lung cancer campaign

pharmaphorum

For World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the company’s ‘Do It Yourself’ campaign launched in the North East to raise awareness of lung cancer symptoms. As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

McKinsey Settles for $573 Million Over Role in Opioid Crisis

NY Times

The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.

article thumbnail

J&J asks FDA for emergency clearance of coronavirus vaccine

Bio Pharma Dive

With J&J's application filed, the FDA will start reviewing study results which the company says show its shot to be 66% effective against moderate or severe COVID-19.

article thumbnail

Thursday pharma headlines

World of DTC Marketing

SUMMARY: The industry is facing several challenges on several fronts. Amgen is laying off people because of their poor financial outlook. Merck’s old drugs are under more scrutiny, and anti-vaxxers are causing problems by cherry-picking unreliable information. Amgen announced that it’s laying off a significant number of people, most from the salesforce, under the guise that they’re going “digital.” Let’s be honest: this is a way to inflate a company’s st

article thumbnail

Almirall, Happify partner on digital tool for psoriasis mental health

pharmaphorum

It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Family cancer experience informs eHealth company

Outsourcing Pharma

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

article thumbnail

With $588M IPO, Sana leads wave of new biotechs going public

Bio Pharma Dive

Nine other drug developers are set to price initial public offerings this week, extending a record run of financing activity from last year. Sana's is one of the largest in history.

article thumbnail

Why can’t pharma unite to fight common complaint

World of DTC Marketing

SUMMARY: The biggest argument against pharma is the cost of prescription drugs. Pharma could do something about this by simply uniting to make it easier for patients who can’t afford their medications to get them free or at little cost. OK, I will be the first to admit that pharma has problems and has not put patients first, but the reality is that the pharmaceutical industry is a business.

Drugs 180
article thumbnail

AstraZeneca to supply nine million more vaccines to EU

pharmaphorum

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses. At the end of last week, the European Commission was forced into an embarrassing U-Turn when it tried to impose restrictions on COVID-19 vaccines exported from the bloc.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Here’s Why the Approval of Lupkynis Has Biotech Investors Buzzing

XTalks

The US Food and Drug Administration (FDA) has approved the first oral drug for lupus nephritis called Lupkynis (voclosporin). This drug — developed by Vancouver, Canada-based Aurinia Pharmaceuticals — is used to treat a kidney disease that is caused by lupus which can lead to kidney failure, heart complications and even death. The medicine is given alongside an immunosuppressant to treat adults with active lupus nephritis.

Drugs 105
article thumbnail

Ken Frazier to step down as Merck CEO

Bio Pharma Dive

Frazier, who's retiring after a three-decade career at Merck, will hand the reins to CFO Robert Davis at the end of June. While Frazier's tenure was framed by the success of Keytruda, his leadership extended far beyond Merck's walls.

300
300
article thumbnail

As Virus Variants Spread, ‘No One Is Safe Until Everyone Is Safe’

NY Times

Rich countries are cornering the market on coronavirus vaccines, leaving poorer regions as potential breeding grounds for variants, like one found in South Africa, that could make vaccines less effective.

article thumbnail

UK biotech investment at record levels amid COVID-19

pharmaphorum

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

DrugPatentWatch featured in Inc Magazine

Drug Patent Watch

DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Bayer agrees to help CureVac produce coronavirus vaccine

Bio Pharma Dive

Already a partner on the shot's development, Bayer will chip in on manufacturing too, pledging to make 160 million doses in 2022.

article thumbnail

Switzerland Delays AstraZeneca Vaccine Approval, Wanting More Data

BioSpace

The Swiss health authority Swissmedic rejected AstraZeneca’s rolling authorization application for its COVID-19 vaccine a few days ago, saying more data is needed “to obtain more information about safety, efficacy, and quality.

article thumbnail

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance

pharmaphorum

By Jennifer Mercer , CEO of Metazoa. Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies. . Salesforce org management is usually not the headliner for CIOs and CTOs looking to catch up on executive-level trends and issues pertaining to technology.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

NICE green light for GSK's Nucala

Pharma Times

Final guidance on the drug's use to treat patients with severe eosinophilic asthma on the NHS has now been published

Drugs 126
article thumbnail

Gilead sales propped up by COVID-19 drug Veklury

Bio Pharma Dive

Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere.

Sales 294
article thumbnail

Kessler Foundation awarded three grants for spinal cord injury research studies

Scienmag

Craig H. Neilsen Foundation ensures ongoing support for studies delayed by effects of pandemic. Funding provided for research addressing environmental barriers, chronic pain and racial disparities that affect individuals with spinal cord injury Credit: Kessler Foundation/Jody Banks EAST HANOVER, NJ. February 5, 2021. Kessler Foundation scientists received three spinal cord injury research grants from the […].

article thumbnail

Five Super Bowl LV Food Ads to Watch This Year

XTalks

Super Bowl LV will be played on February 7, 2021 at the Raymond James Stadium in Tampa, Florida where the Kansas City Chiefs and the Tampa Bay Buccaneers will compete to win the 55 th Super Bowl. The Super Bowl is watched by 102 million people, and the advertisements are just as highly anticipated as the outcome of the game itself. A Super Bowl commercial in 2019 cost between $5.1 and $5.3 million for a 30-second slot, according to Bloomberg.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.